Development and Preliminary Evaluation of TFIB, a New Bimodal Prosthetic Group for Bioactive Molecule Labeling.

The new readily available prosthetic group, tetrafluorophenyl 4-fluoro-3-iodobenzoate (TFIB), designed for both molecular imaging and targeted radionuclide therapy purposes was radiolabeled either with fluorine or iodine radionuclides with excellent radiochemical yields and purities. These radiolabeled tags were conjugated to N,N-diethylethylenediamine to give melanin-targeting radiotracers [ (125) I]9 and [ (18) F]9, which were successfully evaluated by PET and gamma scintigraphic imaging in B16F0 pigmented melanoma-bearing C57BL/6J mice. Then, radiolabeled [ (125) I]/[ (18) F]TFIB was used to tag tumor-targeting peptides (i.e., PEG3[c(RGDyK)]2 and NDP-MSH targeting αvβ3 integrin and MC1R receptors, respectively) in mild conditions and with good radiochemical yields (47-83% d.c.) and purities (>99%). The resulting radiolabeled peptides were assessed both in vitro and by PET imaging in animal models.

[1]  N. Moins,et al.  Synthesis, radiofluorination, and in vivo evaluation of novel fluorinated and iodinated radiotracers for PET imaging and targeted radionuclide therapy of melanoma. , 2013, Journal of medicinal chemistry.

[2]  R. Zimmermann.  Why are investors not interested in my radiotracer? The industrial and regulatory constraints in the development of radiopharmaceuticals. , 2013, Nuclear medicine and biology.

[3]  Xiaoyuan Chen,et al.  N-Succinimidyl 4-[18F]-fluoromethylbenzoate-labeled dimeric RGD peptide for imaging tumor integrin expression , 2012, Amino Acids.

[4]  Rhona A. Berganos,et al.  First Experience with Clinical-Grade [18F]FPP(RGD)2: An Automated Multi-step Radiosynthesis for Clinical PET Studies , 2012, Molecular Imaging and Biology.

[5]  Meng-Yi Jin,et al.  Cobalt—Xantphos‐Catalyzed, LiCl‐Mediated Preparation of Arylzinc Reagents from Aryl Iodides, Bromides, and Chlorides. , 2011 .

[6]  M·阿沃里.  Iodine radiolabelling method , 2010 .

[7]  M. Kassiou,et al.  Fluorine-18 Chemistry for PET: A Concise Introduction , 2010 .

[8]  R. Chan,et al.  Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2). , 2010, Journal of medicinal chemistry.

[9]  A. Cuthbertson,et al.  One step radiosynthesis of 6-[(18)F]fluoronicotinic acid 2,3,5,6-tetrafluorophenyl ester ([(18)F]F-Py-TFP): a new prosthetic group for efficient labeling of biomolecules with fluorine-18. , 2010, Journal of medicinal chemistry.

[10]  L. Moroder,et al.  Protein Iodination by Click Chemistry , 2009, Chembiochem : a European journal of chemical biology.

[11]  S. Gambhir,et al.  Small-Animal PET of Melanocortin 1 Receptor Expression Using a 18F-Labeled α-Melanocyte-Stimulating Hormone Analog , 2007, Journal of Nuclear Medicine.

[12]  W. Cai,et al.  18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of αvβ3 integrin expression , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  Wei Zhang,et al.  Synthetic applications of fluorous solid-phase extraction (F-SPE). , 2006, Tetrahedron.

[14]  P. Knochel,et al.  Efficient synthesis of functionalized organozinc compounds by the direct insertion of zinc into organic iodides and bromides. , 2006, Angewandte Chemie.

[15]  M. Zalutsky,et al.  Preparation of N-succinimidyl 3-[*I]iodobenzoate: an agent for the indirect radioiodination of proteins , 2006, Nature Protocols.

[16]  J. Valliant,et al.  A new strategy for preparing molecular imaging and therapy agents using fluorine-rich (fluorous) soluble supports. , 2006, Journal of the American Chemical Society.

[17]  D. Wilbur,et al.  Radiohalogens for imaging and therapy. , 2005, Chemical Society reviews.

[18]  M. Glaser,et al.  Applications of positron-emitting halogens in PET oncology (Review). , 2003, International journal of oncology.

[19]  S. Jurisson,et al.  In vivo evaluation of 99mTc/188Re-labeled linear alpha-melanocyte stimulating hormone analogs for specific melanoma targeting. , 1999, Nuclear medicine and biology.

[20]  M. Zalutsky,et al.  Enhanced binding and inertness to dehalogenation of alpha-melanotropic peptides labeled using N-succinimidyl 3-iodobenzoate. , 1996, Bioconjugate chemistry.

[21]  H. Burns,et al.  Synthesis and radioiodination of N-Boc-p-(tri-n-butylstannyl)-L-phenylalanine tetrafluorophenyl ester: preparation of a radiolabeled phenylalanine derivative for peptide synthesis. , 1993, Bioconjugate chemistry.

[22]  Wilbur Ds.  Radiohalogenation of proteins: An overview of radionuclides, labeling methods and reagents for conjugate labeling , 1992 .

[23]  W. Hunter,et al.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. , 1973, The Biochemical journal.

[24]  Lloyd M. Smith,et al.  A tetrafluorophenyl activated ester self-assembled monolayer for the immobilization of amine-modified oligonucleotides. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[25]  D. Wilbur,et al.  Radiohalogenation of proteins: an overview of radionuclides, labeling methods, and reagents for conjugate labeling. , 1992, Bioconjugate chemistry.